- Home
- AVD vs MBOT Comparison
AVD vs MBOT Comparison
Compare AVD & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVD | MBOT |
|---|---|---|
| Founded | 1969 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.2M | 126.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AVD | MBOT |
|---|---|---|
| Price | $3.82 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.00 | $8.75 |
| AVG Volume (30 Days) | 208.3K | ★ 2.0M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $530,073,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.54 | $3,119.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.28 | $1.08 |
| 52 Week High | $6.33 | $4.67 |
Technical Indicators
Market Signals| Indicator | AVD | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 33.73 | 38.43 |
| Support Level | $3.82 | $2.06 |
| Resistance Level | $4.04 | $2.14 |
| Average True Range (ATR) | 0.16 | 0.12 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 3.62 | 5.83 |
Price Performance
Historical ComparisonAbout AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.